Viroclinics-DDL Revenue and Competitors
Estimated Revenue & Valuation
- Viroclinics-DDL's estimated annual revenue is currently $62.2M per year.
- Viroclinics-DDL's estimated revenue per employee is $252,663
Employee Data
- Viroclinics-DDL has 246 Employees.
- Viroclinics-DDL grew their employee count by -25% last year.
Viroclinics-DDL Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $62.2M | 246 | -25% | N/A | N/A |
What Is Viroclinics-DDL?
Viroclinics operates at a global level, being the preferred virology testing laboratory for several of the top-10 Biopharmaceutical companies. As a virology contract research organization, we serve the biopharmaceutical community with our preclinical, clinical diagnostic, research & development and clinical trial logistics services. Our extensive experience with clinical and preclinical studies for viruses, including our specialty in respiratory viruses, puts us at the forefront for supporting the development of vaccines, antibodies and antiviral compounds targeting viral infectious diseases. For more information, please visit: www.viroclinics.com / www.ddl.nl
keywords:N/AN/A
Total Funding
246
Number of Employees
$62.2M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Viroclinics-DDL's People
Name | Title | Email/Phone |
---|---|---|
1 | Study Director (Pre-clinical services) | Reveal Email/Phone |
2 | Clinical Data Officer | Reveal Email/Phone |
3 | Senior Coordinator Global Logistics | Reveal Email/Phone |
4 | ML-3/BSL-3 Laboratory Technician | Reveal Email/Phone |
5 | Technician logistics | Reveal Email/Phone |
6 | Assay Development & Validation Specialist | Reveal Email/Phone |
7 | ML-III/BSL-3 Technician | Reveal Email/Phone |
8 | Preclinical Services | Reveal Email/Phone |
9 | Technician | Reveal Email/Phone |
10 | Compliance officer (QS) | Reveal Email/Phone |
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 270 | 35% | N/A |
#2 | $59.7M | 270 | 53% | N/A |
#3 | $60.7M | 276 | 5% | N/A |
#4 | $44.3M | 278 | 4% | N/A |
#5 | N/A | 280 | 5% | N/A |